⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6159037 | 1.00 | — | — | |
| SCHEMBL11090141 | 0.97 | — | — | |
| SCHEMBL5689354 | 0.79 | — | — | |
| SCHEMBL2235565 | 0.79 | — | — | |
| SCHEMBL15421837 | 0.75 | FDPS (0.43) | — | |
| SCHEMBL5696081 | 0.74 | ALDH1A1 (0.32) | — | |
| SCHEMBL5696065 | 0.72 | SMPD1 (0.47) | — | |
| SCHEMBL9733997 | 0.72 | SMPD1 (0.47) | — | |
| SCHEMBL5696055 | 0.72 | GRM2 (0.43) | — | |
| SCHEMBL6882712 | 0.71 | MEN1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4452781-A | Method of treating bacterial viral or parasitic diseases | PETROVICH VOJISLAV | 1984-06-05 | — | — | US | claimed |
| JP-6199781-A | — | — | None | — | — | JP | disclosed |
| WO-2022222907-A1 | THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 中国海洋大学 | 2022-10-27 | — | — | WO | disclosed |
| US-10308597-B2 | Inhibitors of creatine transport and uses thereof | RGENIX, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-20170050924-A1 | INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF | INSPIRNA, INC. | 2017-02-23 | — | — | US | disclosed |
| EP-1874800-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | Karyon-CTT Ltd (FI) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006114478-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2006-11-02 | — | — | WO | disclosed |
| EP-0900210-B1 | ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES | NOVARTIS AG (CH) | 2005-02-09 | — | — | EP | disclosed |
| US-6300519-B1 | REACTING HYDRAZINE DERIVATIVE WITH EPOXIDE COMPOUND | NOVARTIS FINANCE CORPORATION | 2001-10-09 | — | — | US | disclosed |
| US-6166004-A | Combinations of HIV protease inhibitors with reverse transcriptase inhibitors | NOVARTIS FINANCE CORPORATION (US) | 2000-12-26 | — | — | US | disclosed |
| US-6110946-A | AN ENZYME INHIBITORS OF RETROVIRAL ASPARTATE PROTEASE FOR THE TREATMENT OF AIDS | NOVARTIS FINANCE CORPORATION (US) | 2000-08-29 | — | — | US | disclosed |
| EP-0900210-A1 | ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES | Novartis AG (CH) | 1999-03-10 | — | — | EP | disclosed |
| US-5849911-A | Antivirally active heterocyclic azahexane derivatives | NOVARTIS FINANCE CORPORATION (US) | 1998-12-15 | — | — | US | disclosed |
| WO-1997040029-A1 | ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES | NOVARTIS AG (CH) | 1997-10-30 | — | — | WO | disclosed |
| JP-H06199781-A | PRODUCTION OF OPTICALLY ACTIVE 4-MERCAPTO-2-PYRROLIDONE DERIVATIVE AND ITS SYNTHETIC INTERMEDIATE | TANABE SEIYAKU CO LTD | 1994-07-19 | — | — | JP | disclosed |
| US-4452781-A | Method of treating bacterial viral or parasitic diseases | PETROVICH VOJISLAV | 1984-06-05 | — | — | US | disclosed |
| US-4452781-A | Method of treating bacterial viral or parasitic diseases | PETROVICH VOJISLAV | 1984-06-05 | — | — | US | disclosed |
| US-4204064-A | FOR TREATMENT OF SKIN OR SCALP | L'OREAL (FR) | 1980-05-20 | — | — | US | disclosed |
| US-4085217-A | DERIVATIVES OF CYSTEINE OR CYSTEAMINE | L'OREAL (FR) | 1978-04-18 | — | — | US | disclosed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | disclosed |